Qlife Holding AB (4HG0) AI Stock Analysis

Qlife Holding AB

(Frankfurt:4HG0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue accelerationThe sharp increase in trailing revenue indicates growing commercial activity and potential customer adoption of Qlife’s diagnostic offering. Although the base remains small, continued expansion could improve operating leverage and support a more scalable business model over the next several quarters.

Negative Factors

Severe unprofitabilityExtremely negative margins show that Qlife has not yet reached an economically sustainable level of operations. Persistent losses suggest revenue growth is currently insufficient to cover the cost base, limiting internal funding capacity and making successful scaling essential to future profitability.

Qlife Holding AB (4HG0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 2.83M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.6
Beta (1Y): 1.31
Revenue Growth: 234.91%
EPS Growth: 55.42%
Country: Germany
Employees: 2
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Qlife Holding AB Business Overview & Revenue Model

Company Description

Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehen...

Qlife Holding AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:4HG0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CEVI	83Outperform	SEK 4.67B	33.84	15.23%	1.41%	1.95%	-8.91%
SE:SECT.B	79Outperform	SEK 67.51B	105.81	30.26%	0.38%	13.94%	5.70%
SE:SEZI	57Neutral	SEK 532.17M	-5.46	-35.44%	―	18.56%	28.11%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:ACARIX	33Underperform	SEK 223.04M	-5.29	-100.09%	―	65.82%	41.28%
SE:SCIB	30Underperform	SEK 174.38M	-0.78	-303.61%	―	51.21%	42.24%

* Healthcare Sector Average

Performance Comparison

DE:4HG0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:4HG0	Qlife Holding AB	0.08	-0.09	-53.57%
SE:CEVI	CellaVision AB	195.60	17.76	9.98%
SE:SEZI	Senzime AB	3.38	-2.45	-41.94%
SE:SCIB	SciBase Holding AB	12.35	-13.24	-51.74%
SE:SECT.B	Sectra AB Class B	346.00	49.17	16.56%
SE:ACARIX	Acarix AB	0.18	-0.10	-35.61%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Qlife Holding AB AI Stock Analysis